Development
SOPHiA GENETICS SA
SOPH
$3.13
$0.082.62%
NASDAQ
| 12/31/2023 | 09/30/2023 | ||||
|---|---|---|---|---|---|
| Revenue | 4.57% | 8.30% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 4.57% | 8.30% | |||
| Cost of Revenue | 2.37% | 0.46% | |||
| Gross Profit | 5.55% | 12.20% | |||
| SG&A Expenses | 8.46% | -7.84% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 76.27% | -1,719.51% | |||
| Total Operating Expenses | 9.50% | -6.42% | |||
| Operating Income | -14.36% | 17.47% | |||
| Income Before Tax | -77.84% | 36.57% | |||
| Income Tax Expenses | -97.32% | 309.59% | |||
| Earnings from Continuing Operations | -74.05% | 35.39% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -74.05% | 35.39% | |||
| EBIT | -14.36% | 17.47% | |||
| EBITDA | -23.89% | 20.39% | |||
| EPS Basic | -74.20% | 35.97% | |||
| Normalized Basic EPS | -77.75% | 37.12% | |||
| EPS Diluted | -74.20% | 35.97% | |||
| Normalized Diluted EPS | -77.75% | 37.12% | |||
| Average Basic Shares Outstanding | -0.07% | 0.89% | |||
| Average Diluted Shares Outstanding | -0.07% | 0.89% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||